FLGT vs XLV
Fulgent Genetics Inc (FLGT) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported FLGT revenue for 2026-06-30 was $156.5M. Net income was -$54.4M. FLGT currently screens at market cap $586.6M.
XLV does not have a complete income-statement cache yet.
FLGT currently screens at market cap $586.6M. XLV currently screens at market cap $0.
Not investment advice. Open the FLGT and XLV stock pages for the full models.
Not investment advice.